AstraZeneca halts phase III trial of ZIBOTENTAN in non-metastatic castrate resistant prostate cancer
7 February 2011 | By AstraZeneca
AstraZeneca today announced that the phase III ENTHUSE Study 15...
List view / Grid view
News
AstraZeneca and Targacept initiate phase IIB clinical trial of TC-5214 as a switch monotherapy treatment for major depressive disorder
7 February 2011 | By AstraZeneca
This study is in addition to the companies’ Phase III RENAISSANCE programme for TC-5214...
US FDA assigns new PDUFA date for BRILINTA (ticagrelor tablets)
4 February 2011 | By AstraZeneca
AstraZeneca announced today that the US FDA has acknowledged receipt of the company’s reply to the Complete Response Letter (CRL) for the ticagrelor New Drug Application (NDA)...
NextPharma Technologies appoint new Quality Director at its Braine-l’Alleud site in Belgium
3 February 2011 | By NextPharma Technologies
NextPharma the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical and biotech industry, is pleased to announce the appointment of Brigitte Genard as Quality Director at its sterile contract development and manufacturing site in Braine-l’Alleud, Belgium.
Aesica announces European appointments
3 February 2011 | By Aesica Pharmaceuticals
Following the recent announcement that it has signed contracts ahead of acquiring three manufacturing sites from UCB, Aesica Pharmaceuticals has appointed a team...
Andrew Packman to lead PwC’s UK pharmaceutical and life sciences business
3 February 2011 | By PwC
PwC has announced the appointment of Andrew Packman as head of the firm’s UK pharmaceutical and life sciences business...
Sigma Life Science & Cofactor Genomics develop rat genome database
2 February 2011 | By kdm communications limited
Plans include the generation and analyzing of sequence data, and to provide the samples and to host a new, free public database...
Exco InTouch introduces unique ‘Free SMS’ and ‘Free Data Download’ features
1 February 2011 | By The Scott Partnership
New measures will help drive down sponsor costs within clinical trials...
Valeant Pharmaceuticals to Acquire PharmaSwiss S.A.
1 February 2011 | By Valeant Pharmaceuticals International Inc.
Valeant Pharmaceuticals International, Inc. and PharmaSwiss S.A. announced today that they have signed a binding agreement for Valeant to acquire PharmaSwiss...
Owen Mumford Limited appoints new General Manager
1 February 2011 | By Karen Taylor PR
Jonathan Byrne has been appointed General Manager of Owen Mumford’s Cotswold Division...
European Commission approves nasal spray vaccine FLUENZ for the prevention of seasonal influenza in children
1 February 2011 | By AstraZeneca
The European Commission has granted marketing authorisation to FLUENZ Influenza Vaccine...
Optibrium to preview new in silico drug discovery platform
31 January 2011 | By The Scott Partnership
Optibrium will be providing a sneak preview of the next generation of StarDrop at the Molecular Medicine Tri-Conference 2011...
Tecan and Sword Diagnostics launch immunoassay detection technology
31 January 2011 | By kdm communications limited
The reagents are initially being offered for sale in the USA, for use with the Infinite M1000 and Infinite 200 PRO series readers...
FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo®
31 January 2011 | By Novartis
The FDA approval of Menveo for use in children 2 to 10 years of age is based on Phase III trial data involving 5,297 participants in that age group...
FDA approves Rituxan/MabThera for first-line maintenance use in follicular lymphoma
31 January 2011 | By Roche
Roche announced that the U.S. FDA approved Rituxan/MabThera as a maintenance treatment for patients with advanced follicular lymphoma...
